These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14927853)

  • 21. [Temperate SM phage from Pseudomonas aeruginosa as a vector for cloning genetic information].
    Kul'ba AM; Gorelyshev AS; Evtushenkov AN; Fomichev IuK
    Mol Gen Mikrobiol Virusol; 1991 Dec; (12):26-9. PubMed ID: 1787841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage grouping of Pseudomonas aeruginosa, with special emphasis on lysotypes occurring in infected burns.
    GRABER CD; LATTA R; VOGEL EH; BRAME R
    Am J Clin Pathol; 1962 Jan; 37():54-62. PubMed ID: 13900914
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of the first double-stranded RNA bacteriophage infecting Pseudomonas aeruginosa.
    Yang Y; Lu S; Shen W; Zhao X; Shen M; Tan Y; Li G; Li M; Wang J; Hu F; Le S
    Sci Rep; 2016 Dec; 6():38795. PubMed ID: 27934909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of two bacteriophages with strong in vitro antimicrobial activity against Pseudomonas aeruginosa isolated from dogs with ocular infections.
    Santos TM; Ledbetter EC; Caixeta LS; Bicalho ML; Bicalho RC
    Am J Vet Res; 2011 Aug; 72(8):1079-86. PubMed ID: 21801066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Pseudomonas polycolor to Pseudomonas aeruginosa bacteriophages.
    HOFF JC; DRAKE CH
    J Bacteriol; 1960 Sep; 80(3):420-1. PubMed ID: 13714989
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacteriophage therapy in implant-related infections: an experimental study.
    Yilmaz C; Colak M; Yilmaz BC; Ersoz G; Kutateladze M; Gozlugol M
    J Bone Joint Surg Am; 2013 Jan; 95(2):117-25. PubMed ID: 23324958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-virus action of some Bulgarian plants on reproduction of the influenza virus.
    Manolova N; Nikolov P; Bakalova D; Gagov I
    C R Acad Bulg Sci; 1969; 22(5):591-3. PubMed ID: 5396355
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiviral activity of Flos verbasci infusion against influenza and Herpes simplex viruses.
    Zgórniak-Nowosielska I; Grzybek J; Manolova N; Serkedjieva J; Zawilińska B
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):103-8. PubMed ID: 1666504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electron microscopic observations on Pseudomonas aeruginosa bacteriophage.
    SCHULTZ EW; THOMASSEN PR; MARTON L
    Proc Soc Exp Biol Med; 1948; 68(3):451-5. PubMed ID: 18884248
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriophage of Pseudomonas aeruginosa with unfamiliar head morphology.
    TAKEYA K; MORI R; UEDA S; TODA T
    J Bacteriol; 1959 Sep; 78(3):332-5. PubMed ID: 13836687
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibiotic action of substances in higher plants, particularly in Alliaria officinalis and other leeklike plants on Bacterium pyocyaneum].
    RUDAT KD
    J Hyg Epidemiol Microbiol Immunol; 1957; 1(2):213-24. PubMed ID: 13502548
    [No Abstract]   [Full Text] [Related]  

  • 33. Interference with multiplication of Pc phage by a factor produced by exposure of Pseudomonas aeruginosa to inactivated Pc phage.
    MERCER CK; MILLS RF
    J Gen Microbiol; 1960 Oct; 23():253-6. PubMed ID: 13769543
    [No Abstract]   [Full Text] [Related]  

  • 34. VARIATIONS IN RESTRICTION AND MODIFICATION OF BACTERIOPHAGE FOLLOWING INCREASE OF GROWTH TEMPERATURE OF PSEUDOMONAS AERUGINOSA.
    HOLLOWAY BW
    Virology; 1965 Apr; 25():634-42. PubMed ID: 14329136
    [No Abstract]   [Full Text] [Related]  

  • 35. [EPIDEMIC OF PSEUDOMONAS AERUGINOSA INFECTION TRACED WITH THE HELP OF PHAGE-TYPING].
    ZANEN HC
    Ned Tijdschr Geneeskd; 1963 Sep; 107():1700-3. PubMed ID: 14050948
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stability of P. pyocyanea lysotypes in vivo and in vitro].
    PAVLATOU M; KAKLAMANI E
    Ann Inst Pasteur (Paris); 1962 Mar; 102():300-8. PubMed ID: 14484586
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of some plant extracts and antibiotics on Pseudomonas aeruginosa isolated from various burn cases.
    Al-Saimary IE; Bakr SS; Jaffar T; Al-Saimary AE; Salim H; Al-Muosawi R
    Saudi Med J; 2002 Jul; 23(7):802-5. PubMed ID: 12174229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isolation and analysis of Pseudomonas aeruginosa PAO mutants resistant to nonlysogenic bacteriophages].
    Kulakov LA; Mazepa VN; Boronin AM
    Genetika; 1985 Jan; 21(1):39-45. PubMed ID: 3918919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The behavior of a temperate phage of Pseudomonas aeruginosa compared with that of a serologically related, virulent mutant.
    DICKINSON L
    J Gen Microbiol; 1954 Aug; 11(1):105-13. PubMed ID: 13192308
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antiviral plants].
    VINCENT D
    Presse Med (1893); 1953 Mar; 61(20):417. PubMed ID: 13074012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.